References
- Catovsky D., Fooks J., Richards S. Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. Br. J. Haemarol. 1989; 72: 141–149
- Singh A.K. A prospective study of the evolution of chronic lymphocytic leukaemia. Leukemia and Lymphoma 1992; 7: 87–97
- Melo J.V., Catovsky D., Galton D. A. G. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of “prolym-phocytoid” transformation. Br. J. Haematol. 1986; 64: 77–86
- Montserrat E., Rozman C. Chronic lymphocytic leukaemia: prognostic factors and natural history. Bailliere's Clin. Haematol. 1993; 6: 849–866
- Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 1983; 31: 13–20
- Gerdes J., Dallenbach F., Lennert K., Lemke H., Stein H. Growth fraction in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol. Oncol. 1984; 2: 365–372
- Hall P.A., Richards M.A., Gregory W.M., d'Ardenne A.J., Lister T.A., Stansfeld A.G. The prognostic significance of Ki-67 immunostaining in non-Hodgkin's lymphomas. J. Pathol. 1985; 154: 223–235
- Cordone I., Matutes E., Catovsky D. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukaemia: correlation with disease activity. Leukemia 1992; 6: 902–906
- De Melo N., Matutes E., Cordone I., Monlla R., Catovsky D. Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders. J. Clin. Pathol. 1992; 45: 660–663
- Brown D.C., Gatter K.C., Mason D.Y. Proliferation in non-Hodgkin's lymphoma: comparison of Ki-67 staining on fine needle aspiration and cryostat sections. J. Clin. Puthol. 1990; 43: 325–328
- Katz R.L., Wojcik E.M., Naggar A.K., Ordonez N.G., Johnston D.A. Proliferation markers in non-Hodgkin's lymphoma. A comparative study between cytophotometric quantitation of Ki-67 and flow cytometric proliferation index on fine needle aspirates. Anal. Quant. Cytol. Histol. 1993; 15: 179–186
- Bennett J.M., Catovsky D., Daniel M-T., Flandrin G., Galton D. A. G., Gralnick H.R., Sultan C., The French-American-British (FAB) Co-operative Group. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J. Clin. Pathol. 1989; 42: 567–584
- Mulligan S.P., Catovsky D. The chronic B-cell leukaemias. Aust. N. Z. J. Med. 1993; 23: 42–50
- Malashenko O.S., Samoilova R.S., Bulicheva T.I. Double immunocytochemical evaluation of lymphoid cell proliferation and lineage in different lymphoproliferative diseases. Gematologia i transfusiologia 1994; 3: 3–7
- Malashenko O.S., Samoilova R.S. The immunocytochemical method for assessment of the proliferative status of lymphoid cells in lymphoproliferative diseases. Klini-cheskaya i laboratornaya diagnostica 1995; 3: 51–54
- Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluation in human malignancies. Semin. Cancer Biol. 1990; 1: 199–206
- Lindh J., Jonsson H., Lenner P., Roos G. “Aggressive” low grade lymphocytic lymphoma can be identified by flow cytometric S-phase determination. Hemarol. Oncol. 1992; 10: 171–179